Aussie health company to expand products internationally
Thomson Geer has advised an Australian health, wellness and beauty company on its joint venture agreement to expand sales of its anti-ageing products in Greater China.
Firms: Thomson Geer (McPherson’s Limited); Bird & Bird (Access Brand Management)
Deal: McPherson’s Limited has signed a joint venture (JV) agreement with Access Brand Management (Access) to expand sales of the Dr LeWinn’s range of anti-ageing products in Greater China.
Key players: The Thomson Geer team consisted of partner David Zwi and associate Nicola Moldrich.
Deal significance: Under the terms of the agreement, Australian-based Access will acquire a 51 per cent stake in a JV entity to be incorporated with McPherson’s in Hong Kong. McPherson’s will transfer to the JV entity certain trademarks registered in China, Hong Kong, Macau and Taiwan, according to a statement from Thomson Geer.
“Access and the JV entity will be granted exclusive distribution rights for Dr LeWinn’s branded products throughout Greater China,” the statement added.
McPherson’s managing director Laurence McAllister said the Dr LeWinn’s range had seen “incredible success” in the Chinese market, with consumers “attracted to its clinically proven formulas and premium products”.
“[The JV will] be targeting further growth of Dr LeWinn’s in Greater China [and also] elevating the value of the brand globally,” Mr McAllister noted.